Miraculins Announces Election of Directors

Miraculins Inc. (TSX VENTURE:MOM) (the "Company"), a medical diagnostic company
focused on acquiring, developing and commercializing diagnostic tests and risk
assessment technologies for unmet clinical needs, announces that at today's
annual and special meeting of shareholders (the "Meeting"), Harry Bloomfield,
Christopher Moreau, William Roberts and Michael Stasiuk were reelected as
directors of the Company to hold office until the next annual meeting of
shareholders, or until their successors are duly elected or appointed. James
Mellon had advised the Company prior to the Meeting that he would not be
standing for reelection.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Miraculins Inc.
Christopher J. Moreau
President & CEO
204-477-7599
204-453-1546 (FAX)
info@miraculins.com
www.miraculins.com

Miraculins Inc. (TSXV:MOM)
過去株価チャート
から 5 2024 まで 6 2024